BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$502M |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$291M |
| 3 |
Amazon
AMZN
|
+$248M |
| 4 |
iShares Expanded Tech-Software Sector ETF
IGV
|
+$230M |
| 5 |
JPMorgan Chase
JPM
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.9B |
| 2 |
Apple
AAPL
|
+$1.82B |
| 3 |
Broadcom
AVGO
|
+$1.66B |
| 4 |
Microsoft
MSFT
|
+$1.21B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$824M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.25% |
| 2 | Consumer Discretionary | 8.22% |
| 3 | Financials | 7.41% |
| 4 | Communication Services | 5.92% |
| 5 | Healthcare | 5.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
Immunocore
IMCR
$1.76B
| $717K | ﹤0.01% |
19,737
-18,439
| -48% | -$626K |
|
3227
WesBanco
WSBC
$4.09B
| $717K | ﹤0.01% |
22,440
+1,114
| +5% | +$35.5K |
|
3228
CALL
On Holding
ONON
$10.8B
| $716K | ﹤0.01% |
169
-1,094
| -87% | -$52.1K |
|
3229
Churchill Downs
CHDN
$6.33B
| $715K | ﹤0.01% |
7,373
-18,048
| -71% | -$1.86M |
|
3230
Betterware México
BWMX
$613M
| $715K | ﹤0.01% |
53,166
+1,264
| +2% | +$15.4K |
|
3231
LeMaitre Vascular
LMAT
$1.88B
| $713K | ﹤0.01% |
8,148
-467
| -5% | -$41.7K |
|
3232
Tidewater
TDW
$4.69B
| $713K | ﹤0.01% |
13,361
+7,112
| +114% | +$390K |
|
3233
NextNav
NN
$3.36B
| $712K | ﹤0.01% |
49,799
+40,881
| +458% | +$645K |
|
|
FBLA
3234
FB Bancorp
FBLA
$250M
| $711K | ﹤0.01% |
59,144
+27,847
| +89% | +$329K |
|
3235
Sable Offshore Corp
SOC
$796M
| $710K | ﹤0.01% |
40,661
-9,378
| -19% | -$240K |
|
|
DX
3236
Dynex Capital
DX
$3.24B
| $710K | ﹤0.01% |
57,736
+16,741
| +41% | +$210K |
|
3237
PUT
Boston Properties
BXP
$10.9B
| $706K | ﹤0.01% |
95
-35
| -27% | -$2.47K |
|
|
CPRX
3238
DELISTED
Catalyst Pharmaceutical
CPRX
| $703K | ﹤0.01% |
35,680
-136,741
| -79% | -$2.81M |
|
3239
EverQuote
EVER
$861M
| $703K | ﹤0.01% |
30,734
-17,967
| -37% | -$434K |
|
|
GLIBA
3240
Liberty Capital Corp Series A GCI Group Common Stock
GLIBA
$1.08B
| $703K | ﹤0.01% |
+18,710
| New | +$665K |
|
3241
GeneDx Holdings
WGS
$2.33B
| $702K | ﹤0.01% |
6,518
+673
| +12% | +$73.3K |
|
3242
Worthington Enterprises
WOR
$2.87B
| $701K | ﹤0.01% |
12,641
-7,120
| -36% | -$449K |
|
3243
KRONOS Worldwide
KRO
$975M
| $701K | ﹤0.01% |
122,145
+55,252
| +83% | +$335K |
|
3244
Peabody Energy
BTU
$3.11B
| $699K | ﹤0.01% |
26,355
+13,573
| +106% | +$242K |
|
|
3245
PUT
Sable Offshore Corp
SOC
$796M
| $698K | ﹤0.01% |
+400
| New | +$10.3K |
|
3246
Inogen
INGN
$153M
| $698K | ﹤0.01% |
85,443
+82,536
| +2,839% | +$617K |
|
3247
Liberty Global Class C
LBTYK
$3.49B
| $697K | ﹤0.01% |
59,324
-20,812
| -26% | -$233K |
|
3248
Envista
NVST
$4.51B
| $695K | ﹤0.01% |
34,120
-67,617
| -66% | -$1.39M |
|
|
AKRO
3249
DELISTED
Akero Therapeutics
AKRO
| $693K | ﹤0.01% |
14,600
+7,125
| +95% | +$345K |
|
|
THR
3250
DELISTED
Thermon Group Holdings
THR
| $690K | ﹤0.01% |
25,821
+22,585
| +698% | +$607K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2025 Portfolio in Review
As of Q3 2025, BNP Paribas Financial Markets held 5,835 positions worth $187B, up 7.3% from $174B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
BNP Paribas Financial Markets withdrew a net $12.2B in Q3 2025, closing 285 positions and reducing 1,776 holdings. Its most notable exit was Hess, an estimated $52.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, BNP Paribas Financial Markets opened a new position in Sharplink Inc worth $25.1M.
- BNP Paribas Financial Markets's largest Q3 2025 buy was Sharplink Inc: 1,474,633 shares worth $25.1M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q3 2025, an estimated $502M increase.
- BNP Paribas Financial Markets's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $1.9B.
- BNP Paribas Financial Markets fully exited Hess in Q3 2025, selling an estimated $52.5M.
- BNP Paribas Financial Markets's ten largest holdings make up 18% of its $187B portfolio in Q3 2025.
- BNP Paribas Financial Markets opened 414 new positions and closed 285 in Q3 2025.
- BNP Paribas Financial Markets's portfolio value rose 7.3% quarter-over-quarter to $187B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2025, filed 13 Nov 2025.